WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006090177) USE OF 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-l,3- CYCLOHEXANEDIONE IN THE TREATMENT OF PARKINSON'S DISEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/090177    International Application No.:    PCT/GB2006/000684
Publication Date: 31.08.2006 International Filing Date: 27.02.2006
IPC:
A61K 31/122 (2006.01), A61P 25/16 (2006.01)
Applicants: SYNGENTA LIMITED [GB/GB]; European Regional Centre, Priestley Road, Surrey Research Park, Guildford, Surrey GU2 7YH (GB) (For All Designated States Except US).
DOE, John, Ernest [GB/GB]; (GB) (For US Only).
STURGESS, Nicholas, Crispinian [GB/GB]; (GB) (For US Only).
TRAVIS, Kim, Zachary [GB/GB]; (GB) (For US Only)
Inventors: DOE, John, Ernest; (GB).
STURGESS, Nicholas, Crispinian; (GB).
TRAVIS, Kim, Zachary; (GB)
Agent: SYNGENTA LIMITED; Intellectual Property Department, Jealott's Hill International Research Centre, P.O. Box No 3538, Bracknell, Berks RG42 6YA (GB)
Priority Data:
0504103.3 28.02.2005 GB
Title (EN) USE OF 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-l,3- CYCLOHEXANEDIONE IN THE TREATMENT OF PARKINSON'S DISEASE
(FR) UTILISATION DE 2-(2-NITRO-4-TRIFLUOROMÉTHYLBENZOYL)-1,3- CYCLOHEXANEDIONE DANS LE TRAITEMENT DE LA MALADIE DE PARKINSON
Abstract: front page image
(EN)The present invention relates to, inter alia, the use of 2-(2-Nitro-4- Trifluoromethylbenzoyl)-1,3-Cyclohexanedione (compound 2) in the treatment of a neurodegenerative disease, such as Parkinson's disease. The invention also relates to the use of the compound depicted as compound 2 or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in the treatment of a neurodegenerative disease such as Parkinson's disease.
(FR)La présente invention concerne notamment l'utilisation de 2-(2-nitro-4-trifluorométhylbenzoyl)-1,3-cyclohexanedione (composé 2) dans le traitement d’une maladie neurodégénérative telle que la maladie de Parkinson. L’invention concerne également l’utilisation du composé décrit comme le composé 2, ou d’un sel pharmaceutiquement acceptable de celui-ci, dans la fabrication d’un médicament pour utilisation dans le traitement d’une maladie neurodégénérative telle que la maladie de Parkinson.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)